» Articles » PMID: 12175898

Tetrandrine Cytotoxicity and Its Dual Effect on Oxidative Stress-induced Apoptosis Through Modulating Cellular Redox States in Neuro 2a Mouse Neuroblastoma Cells

Overview
Journal Life Sci
Publisher Elsevier
Date 2002 Aug 15
PMID 12175898
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Tetrandrine (TET), a plant alkaloid, is known primarily as a non-selective Ca(2+) channel blocker. On the contrary to the cytoprotective effect on ischemia/reperfusion injury, TET has also been reported to cause cytotoxicity. In this study, we wished to understand the apparently disparate effects of this potential drug and thus investigated molecular mechanisms on proliferation and apoptosis and its effect on oxidative stress-induced apoptosis in Neuro 2a mouse neuroblastoma cells. We showed that TET, at high concentrations, induced cell cycle arrest and apoptosis through oxidative stress with following observations. Firstly, 10 microM TET elevated the reactive oxygen species (ROS) level and accordingly depleted glutathione (GSH) content. Secondly, pretreatment with antioxidants (NAC or GSH) protected cells from TET-induced apoptosis. We also demonstrated that treatment with 10 microM TET caused not only induction of p53, p21(waf1), and Bax, but also nuclear translocation of p53 and hypo-phosphorylation of pRb concurrently. Our important finding is that the concentration-dependent dual effect of TET, either inhibiting or promoting cell death induced by H(2)O(2) was observed, probably through regulating redox balance, which was well reflected on the GSH content in each condition. Besides, inhibition of Ca(2+) influx protected cells from H(2)O(2)-induced apoptosis even in the presence of 10 microM TET. Taken together, our data suggest that TET regulation of cellular redox states may play a major role in its dual action of cytotoxicity and cytoprotection.

Citing Articles

Progress on structural modification of Tetrandrine with wide range of pharmacological activities.

Mo L, Zhang F, Chen F, Xia L, Huang Y, Mo Y Front Pharmacol. 2022; 13:978600.

PMID: 36052124 PMC: 9424556. DOI: 10.3389/fphar.2022.978600.


Targeting the two-pore channel 2 in cancer progression and metastasis.

Skelding K, Barry D, Theron D, Lincz L Explor Target Antitumor Ther. 2022; 3(1):62-89.

PMID: 36046356 PMC: 9400767. DOI: 10.37349/etat.2022.00072.


Otoprotective Effects of Stephania tetrandra S. Moore Herb Isolate against Acoustic Trauma.

Yu Y, Hu B, Bao J, Mulvany J, Bielefeld E, Harrison R J Assoc Res Otolaryngol. 2018; 19(6):653-668.

PMID: 30187298 PMC: 6249158. DOI: 10.1007/s10162-018-00690-3.


Tetrandrine protects mouse retinal ganglion cells from ischemic injury.

Li W, Yang C, Lu J, Huang P, Barnstable C, Zhang C Drug Des Devel Ther. 2014; 8:327-39.

PMID: 24711693 PMC: 3968085. DOI: 10.2147/DDDT.S55407.


Tetrandrine combined with gemcitabine and Cisplatin for patients with advanced non-small cell lung cancer improve efficacy.

Liu W, Zhang J, Ying C, Wang Q, Yan C, Jingyue Y Int J Biomed Sci. 2013; 8(1):28-35.

PMID: 23675254 PMC: 3614858.